Personalis (PSNL) Stock Price, Quote, News & History | Benzinga

Personalis Inc (PSNL) Stock Price, Quote, News & History

PSNLNASDAQ

Trade with Public

Trade with Public

$17.08

-0.17-0.99%

At close: Aug 26, 5:00 PM EST

$17.30

0.221.29%

After Hours: 6:04 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$17.18

Close

$17.08

Volume / Avg.

2.18M / 4.15M

Day Range

$16.84 - $17.50

52 Wk Range

4.65 - 18.89

Market Cap

$1.85B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

67

Short Interest

12.29%

Days to Cover

3.61

Recent Personalis, Inc. News

What’s Going On With Tempus AI Stock on Monday?

Tempus AI stock pulls back after a 20% surge as cancer data spotlights its Personalis deal, and FDA clears its pulmonary hypertension AI tool.

Vandana Singh

Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

Treasury's expanded long-bond buybacks knocked yields off 20-month highs and sank the dollar, as gold soars.

Piero Cingari

Benzinga Bulls and Bears: IBM, Super Micro, Tesla

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Benzinga Senior Editor

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Tempus AI acquires Personalis for $1.5B to target the $20B MRD cancer monitoring market. Get full deal details and analysis.

Vandana Singh

Cathie Wood’s Tempus AI Bet Is Bleeding — And the Chart Looks Worse Than Wall Street Thinks

Tempus AI stock has fallen about 16% YTD. Cathie Wood still owns it as ARKK's 4th largest holding while analysts see nearly 38% upside. Here's what the chart says.

Surbhi Jain

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-92.30M

Investing Cash Flow (TTM)

-3.50M

Financing Cash Flow (TTM)

136.40M

Free Cash Flow (TTM)

-100.98M

Capital Expenditure (TTM)

-8.68M

Net Change in Cash (TTM)

40.59M

Analyst Trends and Forecast

1

Mar

1

1

May

2

1

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.67B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

24.16

PB Ratio (TTM)

7.83

Earnings Yield % (TTM)

-6.32%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.20

Company Debt

Total Debt

$898.00K

LT Debt

-

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-$4.26M

Total Cash

$93.97M

Debt to Equity

0.16

Issuance of Debt (TTM)

-$4.26M

Repayment of Debt (TTM)

-$4.26M

Key Statistics

Open

$17.18

Close

$17.08

Volume / Avg.

2.18M / 4.15M

Day Range

$16.84 - $17.50

52 Wk Range

4.65 - 18.89

Market Cap

$1.85B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

67

Short Interest

12.29%

Days to Cover

3.61

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis servi...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Personalis (PSNL) stock?

A

You can purchase shares of Personalis (NASDAQ:PSNL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Personalis (PSNL) competitors?

A

Other companies in Personalis’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for Personalis (PSNL) stock?

A

Personalis has a consensus price target of $13.25.

Q

What is the current price for Personalis (PSNL)?

A

The stock price for Personalis (NASDAQ: PSNL) is $17.3 last updated August 26, 2026 at 6:04 PM EDT.

Q

Does Personalis (PSNL) pay a dividend?

A

There are no upcoming dividends for Personalis.

Q

When is Personalis (NASDAQ:PSNL) reporting earnings?

A

Personalis does not have any upcoming earnings scheduled.

Q

Is Personalis (PSNL) going to split?

A

There is no upcoming split for Personalis.

Q

What sector and industry does Personalis (PSNL) operate in?

A

Personalis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.